Update in the Diagnosis and Management of Central Nervous System Infections

Neurologic Clinics

Volumn 26, Issue 2, 2008, Pages 427-468

  Ziai, Wendy C ^a   Lewin III, John J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ETHAMBUTOL; FLUCYTOSINE; FOSCARNET; GANCICLOVIR; GENTAMICIN; ISONIAZID; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NAFCILLIN; OXACILLIN; PLECONARIL; POSACONAZOLE; PYRAZINAMIDE; RIFAMPICIN; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ACUTE DISEASE; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BONE MARROW SUPPRESSION; BRAIN ABSCESS; BRAIN DISEASE; BRAIN VENTRICULITIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID SHUNTING; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIAGNOSTIC PROCEDURE; DRUG DISTRIBUTION; ENCEPHALITIS; EPIDURAL ABSCESS; HUMAN; IMMUNOMODULATION; KIDNEY FAILURE; MYCOSIS; NEUROANATOMY; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEIZURE; SHUNT INFECTION; SUBDURAL EMPYEMA; VIRUS ENCEPHALITIS;

BACTERIAL INFECTIONS; CENTRAL NERVOUS SYSTEM INFECTIONS; ENCEPHALITIS, VIRAL; HUMANS; MENINGITIS; MYCOSES;

EID: 44349119112     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2008.03.013     Document Type: Review

References (193)

1. Wenger J.D., Hightower A.W., Facklam R.R., et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 162 6 (1990) 1316-1323
2. Quagliarello V., and Scheld W.M. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 327 12 (1992) 864-872
3. Plaut A.G. The IgA1 proteases of pathogenic bacteria. Annu Rev Microbiol 37 (1983) 603-622
4. Fearon D.T. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci USA 75 4 (1978) 1971-1975
5. Rubin L.L., and Staddon J.M. The cell biology of the blood-brain barrier. Annu Rev Neurosci 22 (1999) 11-28
6. Wolburg H., and Risau W. Formation of the blood brain barrier. In: Kettenmann H., and Ransom B. (Eds) (1995), Oxford University Press, Neuroglia. Oxford (UK)
7. Braun J.S., Novak R., Herzog K.H., et al. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 5 3 (1999) 298-302
8. Braun J.S., Novak R., Murray P.J., et al. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis 184 10 (2001) 1300-1309
9. Braun J.S., Sublett J.E., Freyer D., et al. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest 109 1 (2002) 19-27
10. Blamire A.M., Anthony D.C., Rajagopalan B., et al. Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci 20 21 (2000) 8153-8159
11. Paul R., Koedel U., Winkler F., et al. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 126 Pt 8 (2003) 1873-1882
12. Yang G.Y., Gong C., Qin Z., et al. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res 69 1 (1999) 135-143
13. Dietrich J.B. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J Neuroimmunol 128 1-2 (2002) 58-68
14. Merrill J.E., and Murphy S.P. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav Immun 11 4 (1997) 245-263
15. Petty M.A., and Lo E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 68 5 (2002) 311-323
16. Stamatovic S.M., Dimitrijevic O.B., Keep R.F., et al. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl 96 (2006) 444-450
17. Tuomanen E., Tomasz A., Hengstler B., et al. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 151 3 (1985) 535-540
18. Tofte R.W., Peterson P.K., and Kim Y. Opsonic activity in normal human cerebrospinal fluid for selected bacterial species. Infect Immun 26 (1979) 1093-1098
19. Thea D., and Barza M. Use of antibacterial agents in infections of the central nervous system. Infect Dis Clin North Am 3 (1989) 553-570
20. Hoffmann O., Priller J., Prozorovski T., et al. TRAIL limits excessive host immune responses in bacterial meningitis. J Clin Invest 117 7 (2007) 2004-2013
21. Hosomi N., Ban C.R., Naya T., et al. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab 25 8 (2005) 959-967
22. Oprica M., Van Dam A.M., Lundkvist J., et al. Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse. Acta Neuropathol (Berl) 108 1 (2004) 69-80
23. Aminpour S., Tinling S.P., and Brodie H.A. Role of tumor necrosis factor-alpha in sensorineural hearing loss after bacterial meningitis. Otol Neurotol 26 4 (2005) 602-609
24. Bifrare Y.D., Kummer J., Joss P., et al. Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis. J Infect Dis 191 1 (2005) 40-45
25. Grant G.A., and Janigro D. The blood-brain barrier. In: Youmans J.R., and Becker D.P. (Eds). Youmans Neurological Surgery. 5th edition vol. 1 (2004), Saunders, Philadelphia 153-159
26. Lapointe M., Haines S.J., and Landesman S. Basic principles of antimicrobial therapy of CNS infections. In: Cooper P.R., and Golfinos J.G. (Eds). Head injury. 4th edition vol. 1 (2000), McGraw-Hill, New York 483-498
27. Bleck T., and Greenlee J. Central nervous system infections. In: Mandell G., Bennett J., and Dolin R. (Eds). Principles and practice of infectious diseases. 5th edition vol. 1 (2000), Churchville Livingstone, Philadelphia 950-960
28. Ristuccia A.M., and LeFrock J.L. Cerebrospinal fluid penetration of antimicrobials. Antimicrobial Agents Chemother 45 (1992) 118-152
29. Brivet F.G., Ducuing S., Jacobs F., et al. Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach. Intensive Care Med 31 12 (2005) 1654-1660
30. Tunkel A., and Scheld W. Acute Meningitis. In: Mandell G., Bennett J., and Dolin R. (Eds). Principles and Practice of Infectious Disease. 5th edition vol. 1 (2000), Churchville Livingstone, Phialdelphia 959-997
31. Quagliarello V.J., and Scheld W.M. Treatment of bacterial meningitis. N Engl J Med 336 10 (1997) 708-716
32. van de Beek D., de Gans J., Spanjaard L., et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351 18 (2004) 1849-1859
33. Roos K., Tunkel A., WM, et al. Acute bacterial meningitis in children and adults. In: Scheld W., Whitley R., and Durack D. (Eds). Infections of the central nervous system. 2nd edition (1997), Lippincott-Raven, Philadelphia 335-402
34. Diamond M. Cryptococcal Neoformans (2000), Churchill-Livingstone, New York
35. Durand M.L., Calderwood S.B., Weber D.J., et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328 1 (1993) 21-28
36. Pfister H.W., Feiden W., and Einhaupl K.M. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol 50 6 (1993) 575-581
37. Hussein A.S., and Shafran S.D. Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore) 79 6 (2000) 360-368
38. Igarashi M., Gilmartin R.C., Gerald B., et al. Cerebral arteritis and bacterial meningitis. Arch Neurol 41 5 (1984) 531-535
39. Sejvar J.J. The evolving epidemiology of viral encephalitis. Curr Opin Neurol 19 4 (2006) 350-357
40. Solomon T., Hart I.J., and Beeching N.J. Viral encephalitis: a clinician's guide. Pract Neurol 7 5 (2007) 288-305
41. Chretien F., Belec L., Hilton D.A., et al. Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 22 5 (1996) 394-404
42. Hamilton R.L., Achim C., Grafe M.R., et al. Herpes simplex virus brainstem encephalitis in an AIDS patient. Clin Neuropathol 14 1 (1995) 45-50
43. Bertram M., Schwarz S., and Hacke W. Acute and critical care in neurology. Eur Neurol 38 3 (1997) 155-166
44. Johnson R.T. Acute encephalitis. Clin Infect Dis 23 2 (1996) 219-224 [quiz: 225-216]
45. Schmutzhard E. Viral infections of the CNS with special emphasis on herpes simplex infections. J Neurol 248 6 (2001) 469-477
46. Esiri M.M. Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci 54 2 (1982) 209-226
47. Granwehr B.P., Lillibridge K.M., Higgs S., et al. West Nile virus: where are we now?. Lancet Infect Dis 4 9 (2004) 547-556
48. O'Leary D.R., Marfin A.A., Montgomery S.P., et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 4 1 (2004) 61-70
49. Sejvar J.J., Haddad M.B., Tierney B.C., et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290 4 (2003) 511-515
50. Solomon T., and Vaughn D.W. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 267 (2002) 171-194
51. Pepperell C., Rau N., Krajden S., et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in south-central Ontario. CMAJ 168 11 (2003) 1399-1405
52. Sejvar J.J., Bode A.V., Marfin A.A., et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis 11 7 (2005) 1021-1027
53. Solomon T., and Willison H. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 16 5 (2003) 375-381
54. Alpert S.G., Fergerson J., and Noel L.P. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 136 4 (2003) 733-735
55. Medarov B.I., Multz A.S., Brown W., et al. West Nile meningoencephalitis and rhabdomyolysis. Lancet Infect Dis 5 1 (2005) 2
56. Centers for Disease Control and Prevention. West Nile virus activity-United States, January 1-November 7, 2006. MMWR Morb Mortal Wkly Rep 55 44 (2006) 1204-1205
57. Civen R., Villacorte F., Robles D.T., et al. West Nile virus infection in the pediatric population. Pediatr Infect Dis J 25 1 (2006) 75-78
58. Sagher O., and JH. Surgical management of CNS infections. In: Scheld W., Whitley R., and Durack D. (Eds). Infections of the central nervous system. 2nd edition (1997), Lippincott-Raven, Philadelphia 945-972
59. Wijdicks E. Acute bacterial infections of the central nervous system. In: Wijdicks E. (Ed). Neurologic catastrophes in the emergency department (2000), Butterworth Heinemann, Boston 183-194
60. Armstrong W., Boulis N., and McGillicuddy I. Infections of the central nervous system. In: Crockard H., and Hoff J. (Eds). Neurosurgery: the scientific basis of clincial practice. 3rd edition vol. 2 (2000), Blackwell Science, Oxford 757-783
61. Bleck T., and Greenlee J. Epidural Abscess. In: Mandell G., Bennett J., and Donlin R. (Eds). Principles and Practice of Infectious Diseases. 5th edition vol. 1 (2000), Churchville Livingstone, Philadelphia 1031-1034
62. Zimmerman R., and Girard N. Imaging of intracranial infections. In: Scheld W., and Durack D. (Eds). Infections of the central nervous system. 2nd edition (1997), Lippincott-Raven, Philadelphia
63. Bleck T., and Greenlee J. Subdural Empyema. In: Mandell G., Bennett J., and Donlin R. (Eds). Principles and Practice of Infectious Diseases. 5th edition vol. 1 (2000), Churchville Livingstone, Philadelphia 1028-1031
64. van de Beek D., Campeau N.G., and Wijdicks E.F. The clinical challenge of recognizing infratentorial empyema. Neurology 69 5 (2007) 477-481
65. Wong A.M., Zimmerman R.A., Simon E.M., et al. Diffusion-weighted MR imaging of subdural empyemas in children. AJNR Am J Neuroradiol 25 6 (2004) 1016-1021
66. Salmon J.H. Ventriculitis complicating meningitis. Am J Dis Child 124 1 (1972) 35-40
67. Miyairi I., Causey K.T., DeVincenzo J.P., et al. Group B streptococcal ventriculitis: a report of three cases and literature review. Pediatr Neurol 34 5 (2006) 395-399
68. Smith A. Neonatal bacterial menigitis. In: Scheld W., and Durack D. (Eds). Infections of the central nervous system. 2nd edition (1997), Lippincott-Raven, Philadelphia 328-329
69. Lozier A.P., Sciacca R.R., Romagnoli M.F., et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 51 1 (2002) 170-181 [discussion: 181-2]
70. Lyke K.E., Obasanjo O.O., Williams M.A., et al. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis 33 12 (2001) 2028-2033
71. Holloway K.L., Barnes T., Choi S., et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg 85 3 (1996) 419-424
72. Rebuck J.A., Murry K.R., Rhoney D.H., et al. Infection related to intracranial pressure monitors in adults: analysis of risk factors and antibiotic prophylaxis. J Neurol Neurosurg Psychiatr 69 3 (2000) 381-384
73. Sundbarg G., Nordstrom C.H., and Soderstrom S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg 2 4 (1988) 485-495
74. Korinek A.M., Reina M., Boch A.L., et al. Prevention of external ventricular drain-related ventriculitis. Acta Neurochir (Wien) 147 1 (2005) 39-45 [discussion: 45-6]
75. Swartz M.N. Bacterial meningitis-a view of the past 90 years. N Engl J Med 351 18 (2004) 1826-1828
76. Hasbun R., Abrahams J., Jekel J., et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 345 24 (2001) 1727-1733
77. Steigbigel N.H. Computed tomography of the head before a lumbar puncture in suspected meningitis - is it helpful?. N Engl J Med 345 24 (2001) 1768-1770
78. Mellor D.H. The place of computed tomography and lumbar puncture in suspected bacterial meningitis. Arch Dis Child 67 12 (1992) 1417-1419
79. Joffe A.R. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med 22 4 (2007) 194-207
80. Aronin S.I., Peduzzi P., and Quagliarello V.J. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129 11 (1998) 862-869
81. Coant P.N., Kornberg A.E., Duffy L.C., et al. Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care 8 4 (1992) 200-205
82. Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 9 (2004) 1267-1284
83. Coyle P.K. Overview of acute and chronic meningitis. Neurol Clin 17 4 (1999) 691-710
84. Leib S.L., Boscacci R., Gratzl O., et al. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis 29 1 (1999) 69-74
85. Deutch S., Pedersen L.N., Podenphant L., et al. Broad-range real time PCR and DNA sequencing for the diagnosis of bacterial meningitis. Scand J Infect Dis 38 1 (2006) 27-35
86. Saravolatz L.D., Manzor O., VanderVelde N., et al. Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis. Clin Infect Dis 36 1 (2003) 40-45
87. Garcia-Monco J.C. Central nervous system tuberculosis. Neurol Clin 17 4 (1999) 737-759
88. Girgis N.I., Sultan Y., Farid Z., et al. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 58 1 (1998) 28-34
89. Davis L.E., Rastogi K.R., Lambert L.C., et al. Tuberculous meningitis in the southwest United States: a community-based study. Neurology 43 9 (1993) 1775-1778
90. Thwaites G.E., Chau T.T., and Farrar J.J. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 42 1 (2004) 378-379
91. Bhigjee A.I., Padayachee R., Paruk H., et al. Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis 11 4 (2007) 348-354
92. Gautam N., Aryal M., Bhatta N., et al. Comparative study of cerebrospinal fluid adenosine deaminase activity in patients with meningitis. Nepal Med Coll J 9 2 (2007) 104-106
93. Pai M., Flores L.L., Pai N., et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 3 10 (2003) 633-643
94. Dinnes J., Deeks J., Kunst H., et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 11 3 (2007) 1-196
95. Farrar M.A., and Schreiber R.D. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11 (1993) 571-611
96. Juan R.S., Sanchez-Suarez C., Rebollo M.J., et al. Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis. J Neurol 253 10 (2006) 1323-1330
97. Thwaites G.E., Caws M., Chau T.T., et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 42 3 (2004) 996-1002
98. Sormunen P., Kallio M.J., Kilpi T., et al. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr 134 6 (1999) 725-729
99. Nathan B.R., and Scheld W.M. The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis 22 (2002) 155-165
100. Gendrel D., Raymond J., Assicot M., et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 24 6 (1997) 1240-1242
101. Viallon A., Zeni F., Lambert C., et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 28 6 (1999) 1313-1316
102. Viallon A., Guyomarc'h P., Guyomarc'h S., et al. Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis. Crit Care 9 4 (2005) R344-R350
103. Martinez R., Gaul C., Buchfelder M., et al. Serum procalcitonin monitoring for differential diagnosis of ventriculitis in adult intensive care patients. Intensive Care Med 28 2 (2002) 208-210
104. Dubos F., Moulin F., Gajdos V., et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 149 1 (2006) 72-76
105. Deutch S., Dahlberg D., Hedegaard J., et al. Diagnosis of ventricular drainage-related bacterial meningitis by broad-range real-time polymerase chain reaction. Neurosurgery 61 2 (2007) 306-311 [discussion: 311-2]
106. Pfausler B., Beer R., Engelhardt K., et al. Cell index-a new parameter for the early diagnosis of ventriculostomy (external ventricular drainage)-related ventriculitis in patients with intraventricular hemorrhage?. Acta Neurochir (Wien) 146 5 (2004) 477-481
107. Koskiniemi M., Piiparinen H., Mannonen L., et al. Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. The Study Group. J Neurol Neurosurg Psychiatr 60 2 (1996) 174-178
108. Coren M.E., Buchdahl R.M., Cowan F.M., et al. Imaging and laboratory investigation in herpes simplex encephalitis. J Neurol Neurosurg Psychiatr 67 2 (1999) 243-245
109. De Tiege X., Heron B., Lebon P., et al. Limits of early diagnosis of herpes simplex encephalitis in children: a retrospective study of 38 cases. Clin Infect Dis 36 10 (2003) 1335-1339
110. Romero J.R. Diagnosis and management of enteroviral infections of the central nervous system. Curr Infect Dis Rep 4 4 (2002) 309-316
111. Kaplan S.L., and Mason Jr. E.O. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 11 4 (1998) 628-644
112. Kastrup O., Wanke I., and Maschke M. Neuroimaging of infections. NeuroRx 2 2 (2005) 324-332
113. Kumar R., Kohli N., Thavnani H., et al. Value of CT scan in the diagnosis of meningitis. Indian Pediatr 33 6 (1996) 465-468
114. Andronikou S., Smith B., Hatherhill M., et al. Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol 34 11 (2004) 876-885
115. Kearney B.P., and Aweeka F.T. The penetration of anti-infectives into the central nervous system. Neurol Clin 17 4 (1999) 883-900
116. Houck P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164 6 (2004) 637-644
117. Iregui M., Ward S., Sherman G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122 1 (2002) 262-268
118. Leibovici L., Shraga I., Drucker M., et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244 5 (1998) 379-386
119. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 1 (2000) 146-155
120. Auburtin M., Wolff M., Charpentier J., et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 34 11 (2006) 2758-2765
121. Lepur D., and Barsic B. Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome. Infection 35 4 (2007) 225-231
122. Lu C.H., Huang C.R., Chang W.N., et al. Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg 104 4 (2002) 352-358
123. Schlech III W.F., Ward J.I., Band J.D., et al. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA 253 12 (1985) 1749-1754
124. Schuchat A., Robinson K., Wenger J.D., et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 337 14 (1997) 970-976
125. Pizon A.F., Bonner M.R., Wang H.E., et al. Ten years of clinical experience with adult meningitis at an urban academic medical center. J Emerg Med 30 4 (2006) 367-370
126. Blumberg H.M., Burman W.J., Chaisson R.E., et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167 4 (2003) 603-662
127. Pfausler B., Spiss H., Beer R., et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 98 5 (2003) 1040-1044
128. Luer M.S., and Hatton J. Vancomycin administration into the cerebrospinal fluid: a review. Ann Pharmacother 27 7-8 (1993) 912-921
129. Bayston R., Hart C.A., and Barnicoat M. Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatr 50 11 (1987) 1419-1423
130. Tenney J.H. Bacterial infections of the central nervous system in neurosurgery. Neurol Clin 4 1 (1986) 91-114
131. Calfee D.P., and Wispelwey B. Brain abscess. Semin Neurol 20 3 (2000) 353-360
132. Seydoux C., and Francioli P. Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis 15 3 (1992) 394-401
133. Sofianou D., Selviarides P., Sofianos E., et al. Etiological agents and predisposing factors of intracranial abscesses in a Greek university hospital. Infection 24 2 (1996) 144-146
134. Lu C.H., Chang W.N., and Lui C.C. Strategies for the management of bacterial brain abscess. J Clin Neurosci (Oct 20, 2006)
135. Pruitt A.A. Infections of the nervous system. Neurol Clin 16 2 (1998) 419-447
136. Rigamonti D., Liem L., Sampath P., et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 52 2 (1999) 189-196 [discussion: 197]
137. Nussbaum E.S., Rigamonti D., Standiford H., et al. Spinal epidural abscess: a report of 40 cases and review. Surg Neurol 38 3 (1992) 225-231
138. Whitley R.J., Alford C.A., Hirsch M.S., et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314 3 (1986) 144-149
139. McGrath N., Anderson N.E., Croxson M.C., et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatr 63 3 (1997) 321-326
140. Whitley R.J., and Gnann J.W. Viral encephalitis: familiar infections and emerging pathogens. Lancet 359 9305 (2002) 507-513
141. Kamei S., Sekizawa T., Shiota H., et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatr 76 11 (2005) 1544-1549
142. Roos K.L. Encephalitis. Neurol Clin 17 4 (1999) 813-833
143. Chaudhuri A., and Kennedy P.G. Diagnosis and treatment of viral encephalitis. Postgrad Med J 78 924 (2002) 575-583
144. Anduze-Faris B.M., Fillet A.M., Gozlan J., et al. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS 14 5 (2000) 517-524
145. Balfour Jr. H.H. Antiviral drugs. N Engl J Med 340 16 (1999) 1255-1268
146. Desmond R.A., Accortt N.A., Talley L., et al. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrobial Agents Chemother 50 7 (2006) 2409-2414
147. Rotbart H.A., and Webster A.D. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 32 2 (2001) 228-235
148. Davis L.E. Fungal infections of the central nervous system. Neurol Clin 17 4 (1999) 761-781
149. Go J.L., Kim P.E., Ahmadi J., et al. Fungal infections of the central nervous system. Neuroimaging Clin N Am 10 2 (2000) 409-425
150. Mattiuzzi G., and Giles F.J. Management of intracranial fungal infections in patients with haematological malignancies. Br J Haematol 131 3 (2005) 287-300
151. Stamm A.M., Diasio R.B., Dismukes W.E., et al. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med 83 2 (1987) 236-242
152. Vermes A., Guchelaar H.J., and Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46 2 (2000) 171-179
153. Walsh T.J., Hiemenz J.W., Seibel N.L., et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 26 6 (1998) 1383-1396
154. Wong-Beringer A., Jacobs R.A., and Guglielmo B.J. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 27 3 (1998) 603-618
155. Leenders A.C., Reiss P., Portegies P., et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 11 12 (1997) 1463-1471
156. Kethireddy S., and Andes D. CNS pharmacokinetics of antifungal agents. Expert Opin Drug Metab Toxicol 3 4 (2007) 573-581
157. Groll A.H., Giri N., Petraitis V., et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 182 1 (2000) 274-282
158. Pearson M.M., Rogers P.D., Cleary J.D., et al. Voriconazole: a new triazole antifungal agent. Ann Pharmacother 37 3 (2003) 420-432
159. Schwartz S., Ruhnke M., Ribaud P., et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 106 8 (2005) 2641-2645
160. Lin S.J., Schranz J., and Teutsch S.M. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32 3 (2001) 358-366
161. Pitisuttithum P., Negroni R., Graybill J.R., et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 56 4 (2005) 745-755
162. Kirkpatrick W.R., McAtee R.K., Fothergill A.W., et al. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis. Antimicrobial Agents Chemother 44 3 (2000) 780-782
163. Perfect J.R., Cox G.M., Dodge R.K., et al. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrobial Agents Chemother 40 8 (1996) 1910-1913
164. Hajdu R., Thompson R., Sundelof J.G., et al. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrobial Agents Chemother 41 11 (1997) 2339-2344
165. Hsue G., Napier J.T., Prince R.A., et al. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother 54 1 (2004) 292-294
166. Liu K.H., Wu C.J., Chou C.H., et al. Refractory candidal meningitis in an immunocompromised patient cured by caspofungin. J Clin Microbiol 42 12 (2004) 5950-5953
167. Odio C.M., Araya R., Pinto L.E., et al. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J 23 12 (2004) 1093-1097
168. Patel R. Antifungal agents. Part I. Amphotericin B preparations and flucytosine. Mayo Clin Proc 73 12 (1998) 1205-1225
169. Arthur R.R., Drew R.H., and Perfect J.R. Novel modes of antifungal drug administration. Expert Opin Investig Drugs 13 8 (2004) 903-932
170. de Gans J., and van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 347 20 (2002) 1549-1556
171. van de Beek D., de Gans J., McIntyre P., et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 1 (2007) CD004405
172. Lutsar I., Friedland I.R., Jafri H.S., et al. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. J Antimicrob Chemother 52 4 (2003) 651-655
173. Cabellos C., Martinez-Lacasa J., Tubau F., et al. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother 45 3 (2000) 315-320
174. Viladrich P.F., Gudiol F., Linares J., et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrobial Agents Chemother 35 12 (1991) 2467-2472
175. Ricard J.D., Wolff M., Lacherade J.C., et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 44 2 (2007) 250-255
176. van de Beek D., and de Gans J. Dexamethasone in adults with community-acquired bacterial meningitis. Drugs 66 4 (2006) 415-427
177. Thwaites G.E., Nguyen D.B., Nguyen H.D., et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351 17 (2004) 1741-1751
178. Wen D.Y., Bottini A.G., Hall W.A., et al. Infections in neurologic surgery. The intraventricular use of antibiotics. Neurosurg Clin N Am 3 2 (1992) 343-354
179. Wright P.F., Kaiser A.B., Bowman C.M., et al. The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis. J Infect Dis 143 2 (1981) 141-147
180. McCracken Jr. G.H., Mize S.G., and Threlkeld N. Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet 1 8172 (1980) 787-791
181. Wald S.L., and McLaurin R.L. Cerebrospinal fluid antibiotic levels during treatment of shunt infections. J Neurosurg 52 1 (1980) 41-46
182. Preston S.L., and Briceland L.L. Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli. Ann Pharmacother 27 7-8 (1993) 870-873
183. Haase K.K., Lapointe M., and Haines S.J. Aseptic meningitis after intraventricular administration of gentamicin. Pharmacotherapy 21 1 (2001) 103-107
184. Kaufman B. Infections of cerebrospinal fluid shunts. In: Scheld W., Whitley R., and Durack D. (Eds). Infections of the central nervous system. 2nd edition (1997), Lippincott-Raven, Philadelphia 555-577
185. Falagas M.E., Bliziotis I.A., and Tam V.H. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 29 1 (2007) 9-25
186. Schade R.P., Schinkel J., Roelandse F.W., et al. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg 104 1 (2006) 101-108
187. Schultz M., Moore K., and Foote A.W. Bacterial ventriculitis and duration of ventriculostomy catheter insertion. J Neurosci Nurs 25 3 (1993) 158-164
188. Poon W.S., Ng S., and Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochir Suppl 71 (1998) 146-148
189. Alleyne Jr. C.H., Hassan M., and Zabramski J.M. The efficacy and cost of prophylactic and perioprocedural antibiotics in patients with external ventricular drains. Neurosurgery 47 5 (2000) 1124-1127 [discussion: 1127-9]
190. Guyot L.L., Dowling C., Diaz F.G., et al. Cerebral monitoring devices: analysis of complications. Acta Neurochir Suppl 71 (1998) 47-49
191. Zabramski J.M., Whiting D., Darouiche R.O., et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 98 4 (2003) 725-730
192. Appelgren P., Ransjo U., Bindslev L., et al. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med 24 9 (1996) 1482-1489
193. Kaufman A.M., Lye T., Redekop G., et al. Infection rates in standard vs. hydrogel coated ventricular catheters. Can J Neurol Sci 31 4 (2004) 506-510